VA Center for Clinical Management Research (CCMR), Department of Veterans Affairs Healthcare System, Ann Arbor, Michigan.
Department of Psychiatry, University of Michigan Medical School, Ann Arbor.
JAMA Psychiatry. 2020 Dec 1;77(12):1225-1234. doi: 10.1001/jamapsychiatry.2020.2369.
Chronic pain is common in those with substance use disorders (SUDs) and predicts poorer addiction treatment outcomes. A critical challenge for addiction treatment is to develop effective methods to improve pain-related and substance use-related outcomes for those in treatment for SUDs.
To examine the efficacy of an integrated behavioral pain management intervention (Improving Pain During Addiction Treatment [ImPAT]) for men and women with SUDs to treat pain, functioning, and substance use.
DESIGN, SETTING, AND PARTICIPANTS: In this randomized clinical trial, 8 sessions of ImPAT were compared with 8 sessions of a supportive psychoeducational control (SPC) condition for adults with pain treated at a large residential SUD treatment program. Follow-up occurred at 3, 6, and 12 months postbaseline. A total of 1372 adults were screened, including 960 men and 412 women, and 510 adults were randomized, including 264 men and 246 women. The goal was to recruit approximately equal numbers of men and women to examine results separately in men and women. A total of 470 of 510 participants (92.2%) completed at least 1 follow-up assessment. Data were collected from October 3, 2011, to January 14, 2016. Data were analyzed from February 1, 2016, to May 1, 2020.
ImPAT focused on how a psychosocial model of pain was associated with functioning and relapse prevention and provides skills to manage pain. SPC served as the active control condition and involved discussions of topics like nutrition and the course of addiction, which were intended to be relevant to the patient population and to have face validity but be distinct from the content of ImPAT.
The primary outcomes were pain intensity, pain-related functioning, and behavioral pain tolerance at 12 months. Secondary outcomes were frequency of alcohol and drug use over 12 months.
Of the 510 included participants, the mean (SD) age was 34.8 (10.3) years. A total of 133 men and 122 women were assigned to ImPAT, and a total of 131 men and 124 women were assigned to the SPC condition. Over 12 months of follow-up, randomization to the ImPAT intervention was associated with higher tolerance of pain among men, higher by a mean score of 0.11 (95% CI, 0.03 to 0.18; P = .004; Cohen d = 0.40) at 3 months and by 0.07 (95% CI, -0.01 to 0.19; P = .11; Cohen d = 0.25) at 12 months. Women receiving the ImPAT intervention experienced a reduction in pain intensity from 3 to 12 months, while women receiving the SPC condition experienced an increase in pain intensity, resulting in lower pain in the ImPAT condition by a mean score of 0.58 (95% CI, -0.07 to 1.22; P = .08; Cohen d = -0.22) at 12 months. No differences were found between the ImPAT and SPC conditions on alcohol or drug use.
Behavioral pain management is not typically included in addiction treatment, but the present results indicate that this type of intervention was associated with better pain-related outcomes, including pain tolerance in men and pain intensity in women. Improvements in substance use-related outcomes beyond that achieved by treatment as usual were not observed. Treatment programs should consider providing psychosocial pain management services to augment standard addiction treatment.
ClinicalTrials.gov Identifier: NCT01372267.
慢性疼痛在物质使用障碍(SUD)患者中很常见,并预测成瘾治疗结果较差。成瘾治疗的一个关键挑战是开发有效的方法,以改善接受 SUD 治疗的患者的与疼痛相关和与物质使用相关的结果。
研究一种综合行为疼痛管理干预措施(改善成瘾治疗期间的疼痛[ImPAT])对男性和女性 SUD 患者的疗效,以治疗疼痛、功能和物质使用。
设计、地点和参与者:在这项随机临床试验中,将 8 节 ImPAT 与 8 节支持性心理教育对照(SPC)条件进行比较,用于治疗大型住院 SUD 治疗计划中的疼痛患者。随访发生在基线后 3、6 和 12 个月。共筛查了 1372 名成年人,包括 960 名男性和 412 名女性,510 名成年人被随机分配,包括 264 名男性和 246 名女性。目标是招募大致相等数量的男性和女性,分别对男性和女性进行单独的结果检查。共有 510 名参与者中的 470 名(92.2%)完成了至少 1 次随访评估。数据收集于 2011 年 10 月 3 日至 2016 年 1 月 14 日。数据分析于 2016 年 2 月 1 日至 2020 年 5 月 1 日进行。
ImPAT 专注于心理社会疼痛模型如何与功能和复发预防相关,并提供管理疼痛的技能。SPC 作为活性对照条件,涉及营养和成瘾过程等主题的讨论,旨在与患者群体相关,具有表面效度,但与 ImPAT 的内容不同。
主要结果是 12 个月时的疼痛强度、疼痛相关功能和行为疼痛耐受性。次要结果是 12 个月内的酒精和药物使用频率。
在纳入的 510 名参与者中,平均(SD)年龄为 34.8(10.3)岁。共有 133 名男性和 122 名女性被分配到 ImPAT,131 名男性和 124 名女性被分配到 SPC 条件。在 12 个月的随访中,随机分配到 ImPAT 干预组的男性疼痛耐受性更高,平均得分高 0.11(95%CI,0.03 至 0.18;P=0.004;Cohen d=0.40),在 3 个月时和 0.07(95%CI,-0.01 至 0.19;P=0.11;Cohen d=0.25)在 12 个月时。接受 ImPAT 干预的女性在 3 至 12 个月期间疼痛强度减轻,而接受 SPC 条件的女性疼痛强度增加,导致 12 个月时 ImPAT 条件下疼痛程度降低,平均得分低 0.58(95%CI,-0.07 至 1.22;P=0.08;Cohen d=-0.22)。在酒精或药物使用方面,ImPAT 和 SPC 条件之间没有差异。
行为疼痛管理通常不包括在成瘾治疗中,但目前的结果表明,这种类型的干预与更好的与疼痛相关的结果相关,包括男性的疼痛耐受性和女性的疼痛强度。没有观察到除治疗外的药物使用相关结果的改善。治疗计划应考虑提供心理社会疼痛管理服务,以增强标准成瘾治疗。
ClinicalTrials.gov 标识符:NCT01372267。